IL-15 modulator therapy(Cyrus Biotechnology)
N/A
Report date: 2024/12/27 14:55:46
NME
Base Information
Drug NameIL-15 modulator therapy(Cyrus Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Biotechnology Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A